Product Information
IRBESARTAN 75 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0807 per EA under NDC 62135097630. Its NADAC has been published 42 times since Sep 10, 2025.
Strength
75 mg/1
Manufacturer
Chartwell RX LLCNDC
62135097630
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA077205On Market Since
11/14/2012
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN 75 MG TABLET has been published 42 times since Sep 10, 2025, and over the history we have for it it has declined 24.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0807 per EA |
|---|---|
| All-time high | $0.1074 (Sep 10, 2025) |
| All-time low | $0.0800 (May 20, 2026) |
| 52-week high | $0.1074 |
| 52-week low | $0.0800 |
| Median price | $0.0909 |
| Average price | $0.0897 |
| Largest weekly change | -11.5% (Oct 22, 2025) |
| Weeks tracked | 42 |
| Tracking since | Sep 10, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IRBESARTAN 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 75 MG TABLET, manufactured by Chartwell RX LLC, is $0.0807 per EA (NDC 62135097630), effective Jun 24, 2026.
How has the price of IRBESARTAN 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for IRBESARTAN 75 MG TABLET has declined 24.9%. It has been tracked across 42 weekly CMS publications since Sep 10, 2025.
What are the highest and lowest recorded NADAC prices for IRBESARTAN 75 MG TABLET?
Since Sep 10, 2025, the NADAC for IRBESARTAN 75 MG TABLET has ranged from a low of $0.0800 (May 20, 2026) to a high of $0.1074 (Sep 10, 2025), with a median of $0.0909 per EA.
Are there cheaper alternatives to IRBESARTAN 75 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as IRBESARTAN 75 MG TABLET, but none are currently priced below it.
Who manufactures IRBESARTAN 75 MG TABLET?
IRBESARTAN 75 MG TABLET (NDC 62135097630) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification